Stay updated on Clinical Trial: Olaparib + Abiraterone in Prostate Cancer
Sign up to get notified when there's something new on the Clinical Trial: Olaparib + Abiraterone in Prostate Cancer page.

Latest updates to the Clinical Trial: Olaparib + Abiraterone in Prostate Cancer page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedA new version entry (version 26) was added on 2026-08-27 with an update to the Study Status. The page revision was updated to v3.6.6 on 2026-08-28.SummaryDifference0.4%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedThe page history now shows a new site revision (v3.6.5) replacing the previous (v3.6.4), indicating a software update to the ClinicalTrials.gov history interface.SummaryDifference0.2%

- Check48 days agoChange DetectedA new platform revision label, v3.6.4, was added to the history, replacing the previous v3.6.3. This reflects a software release for the page and does not modify study records or displayed content.SummaryDifference0.1%

- Check69 days agoChange DetectedRevision: v3.6.3 was added to the page history and Revision: v3.6.2 was removed, reflecting a small system update to the site’s version labeling rather than changes to the study record.SummaryDifference0.1%

- Check76 days agoChange DetectedThe study record history displays a new revision entry (v3.6.2) added and an older revision (v3.6.0) removed, updating the page's revision metadata in the history view.SummaryDifference0.1%

- Check83 days agoChange DetectedA new entry dated 2026-06-18 and an additional 2026-05-27 entry (version 25) were added to the study history. The 2026-03-11 entry was removed.SummaryDifference0.3%

Stay in the know with updates to Clinical Trial: Olaparib + Abiraterone in Prostate Cancer
Enter your email address, and we'll notify you when there's something new on the Clinical Trial: Olaparib + Abiraterone in Prostate Cancer page.